Andrew Perlman
8 additional roles and seats, 8 additional attributed investments, 2 verified contacts (2 professional url)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days. Last change: 22 Nov 2021, Latest Sirona Medical Form D equity offering ($40M) on 22 Nov 2021.
Roles
- Greatpoint Investment Management, LLC Managing MemberJan 1, 2017 to present · “Schedule A: PERLMAN, ANDREW, T., MANAGING MEMBER, since 01/2017, ownership E, control person Y”Fact Form ADV
- Greatpoint Investment Management, LLC Managing Partner? to present · “team page: Andrew Perlman / Managing Partner”Fact Firm website
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Sirona Medical | Form D equity offering · $40.0M | Greatpoint Investment Management, LLC | strongly supported · board | Nov 22, 2021 | Inference sec.gov |
| Extend | Form D equity offering · $389,517 | Greatpoint Investment Management, LLC | strongly supported · board | Oct 13, 2021 | Inference sec.gov |
| Extend | Form D equity offering · $16.3M | Greatpoint Investment Management, LLC | strongly supported · board | Aug 23, 2021 | Inference sec.gov |
Board seats and vehicles
- Sirona Medical board seat on a deal Nov 22, 2021 Inference
- Extend board seat on a deal Oct 13, 2021 Inference
- OncoResponse, Inc board seat on a deal Sep 6, 2018 Inference
- Greatpoint Ventures Innovation Fund, L.P. Executive Officer Mar 15, 2017
- Greatpoint Ventures Innovation Parallel Fund, LP Executive Officer Mar 15, 2017
- Greatpoint Ventures Innovation Fund II, L.P. Executive Officer Jan 16, 2018
Timeline
- Nov 22, 2021Form D equity offering in Sirona Medical (Greatpoint Investment Management, LLC)
- Oct 13, 2021
- Aug 23, 2021
- Jan 1, 2017Joined Greatpoint Investment Management, LLC as Managing Member